NCT00568516View on ClinicalTrials.gov

Phase II Study of ASP3550 in Patients With Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

273

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Prostatic Neoplasms
Interventions
DRUG

ASP3550

subcutaneous administration

Trial Locations (8)

Unknown

Chugoku

Chūbu

Hokkaido

Kansai

Kanto

Kyusyu

Shikoku

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY